2014
Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: A retrospective multicenter cohort study
ZAAL, Afra; Ronald P. ZWEEMER; Michal ZIKÁN; Ladislav DUŠEK; Denid QUERLEU et al.Základní údaje
Originální název
Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: A retrospective multicenter cohort study
Autoři
ZAAL, Afra; Ronald P. ZWEEMER; Michal ZIKÁN; Ladislav DUŠEK; Denid QUERLEU; Fabrice LÉCURU; Anne Sophie BATS; Robert JACH; Libor SEVCIK; Petar GRAF; Jaroslav KLAT; Grzegorz DYDUCH; Silvia von MENSDORFF-POULLY; Gemma G. KENTER; René H.M. VERHEIJEN a David CIBULA
Vydání
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2014, 1048-891X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.958
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00075682
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Isolated tumor cells; Low-volume disease; Lymph node dissection; Lymph node metastasis; Micrometastasis; Sentinel lymph node; Survival; Uterine cervical cancer
Štítky
Příznaky
Recenzováno
Změněno: 24. 4. 2015 13:05, Soňa Böhmová
Anotace
V originále
Objective: In this study, we aimed to describe the value of pelvic lymph node dissection (LND) after sentinel lymph node (SN) biopsy in early-stage cervical cancer. Methods: We performed a retrospective multicenter cohort study in 8 gynecological oncology departments. In total, 645 women with International Federation of Gynecology and Obstetrics stage IA to IIB cervical cancer of squamous, adeno, or adenosquamous histologic type who underwent SN biopsy followed by pelvic LND were enrolled in this study. Radioisotope tracers and blue dyewere used to localize the sentinel node, and pathologic ultrastaging was performed. Results: Among the patients with low-volume disease (micrometastases and isolated tumor cells) in the sentinel node, the overall survivalwas significantly better (P = 0.046) ifmore than 16 non-SNs were removed. No such significant difference in survivalwas detected in patients with negative or macrometastatic sentinel nodes. Conclusions: Our findings indicate that in patients with negative or macrometastatic disease in the sentinel nodes, an additional LND did not alter survival. Conversely, our data suggest that the survival of patients with low-volume disease is improved when more than 16 additional lymph nodes are removed. If in a prospective trial our data are confirmed, we would suggest a 2-stage operation.